Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
For further characterization of S-100 protein-positive granular cell tumor (GCT), the expression of osteopontin (OPN) in the tumor cells was compared with other types of Schwannian cell tumors.
|
15998376 |
2005 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Serum level of NEF was higher in esophageal squamous-cell carcinoma patients than in healthy controls, and was significantly correlated with tumor size and tumor distant tumor metastasis.
|
30402846 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
This Review highlights new findings regarding the role of S100 family members in cancer diagnosis and treatment, the contribution of S100 signalling to tumour biology, and the discovery and development of S100 inhibitors for treating cancer.
|
25614008 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Expression of hnRNP A2/B1, hnRNP B1 and S100 A2 was increased in the tumor group when compared with the microscopic tumor-free specimens in 10% versus 5% (n.s.), 91% versus 5% and 65% versus 6%, respectively.
|
17067748 |
2006 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
TYRP1 mRNA expression in 104 lymph node metastases was quantified by real-time PCR and normalised to S100 calcium-binding protein B (S100B) mRNA expression to correct for tumour load.
|
23519055 |
2013 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Immunostaining revealed that the tumors were positive for S-100 protein and vimentin and negative for glial fibrillary acidic protein, actin, and keratin.
|
2305928 |
1990 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
KIT was immunohistochemically detected in 98%, CD34 in 40%, smooth muscle actin in 34%, desmin in 0.2%, and S-100 protein in 14% of the tumors tested.
|
16625094 |
2006 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The immunohistochemical reactivity for epithelial membrane antigen, the lack of reactivity for S-100 protein, and the presence of ultrastructural features of perineurial cells are typical of this tumor.
|
9042282 |
1997 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Immunohistochemically, the tumour cells were positive for S100 protein.
|
9568513 |
1998 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Dermal non-neural granular cell tumor (NNGCT) was first described in 1991 as an S100-negative polypoid non-melanocytic tumor.
|
28266050 |
2017 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Although most of the tumor cells in both malignant melanoma and pleomorphic adenoma were labeled with the anti-sense RNA probe, unlabeled tumor cells were also present in their vicinity, suggesting there was a heterogeneity among the cells in both tumor types with respect to S100 protein mRNA expression.
|
1659204 |
1991 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The percentages of tumors staining positively were as follows: micro-ophthalmia-associated transcription factor, NKI/C3, bcl-1, E-cadherin, and cathepsin K (100%); HMB-45, 4E-binding protein 1, and CD68 (88%); smooth muscle actin and muscle-specific actin (40%); S100 (38%); calponin (20%); desmin (13%); and melan-A, SOX10, and keratin (0%).
|
25267378 |
2014 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Our findings underscore the histomorphological similarities of the two adnexal neoplasms-namely, the expression of S-100 protein ascribed to eccrine differentiation within the tubular and large, pale-staining cells of both entities.
|
9129700 |
1997 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
NEF is a tumor suppressing long non-coding (lnc)RNA in hepatocellular carcinoma.
|
31258706 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Neuropathological studies, assayed by immunohistochemical staining, showed that the tumor sample was positive to antibodies against S-100, CgA, AE1/AE3 (cytokeratin), Ki-67, INI1 and TP53, and was negative to antibodies against Nestin, GFAP, CD133, EMA and AFP.
|
22534715 |
2012 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The lack of substance P and acidic fibroblast growth factor immunoreactivity; the low immunohistochemical expression of CDX2, vesicular monoamine transporter 1, connective tissue growth factor, and prostatic acid phosphatase; the lack of S100-positive sustentacular cells; the strong expression of vesicular monoamine transporter 2; and peculiar ultrastructural features characterize pancreatic EC cell tumors and differentiate them from intestinal ones, although both categories show similar chromosome 18 cytogenetic alterations.
|
21705949 |
2011 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Then, we found that S100B was preferentially expressed in CD133<sup>+</sup> ovarian CSLCs derived from both ovarian cancer cell lines and primary tumors of patients.
|
27501952 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Baseline tumor markers (LDH, S100B), baseline CT imaging biomarkers (tumor burden, Choi density) and CT texture parameters (Entropy, Kurtosis, Skewness, uniformity, MPP, UPP) of the largest target lesion were extracted.
|
31704599 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Three tumors were immunoreactive for S100 protein.
|
27816723 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The murine 18A2/mts1 and its human homolog h-mts1 (S100A4), encoding a Ca2+-binding protein belonging to the S-100 family, are associated with high invasive and metastatic potentials of murine tumors, human tumor cell lines in vitro, and human tumors growing as xenografts.
|
9570150 |
1998 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Immunohistochemical stains performed on the pleural-based mass showed tumor positivity for AE1/AE3, CK5/6, p16, and S-100.
|
28411397 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
S100 proteins take participation in the lung neoplasia through playing intracellular and/or extracellular functions, therefore getting involved in a variety of biological processes such as differentiation, proliferation, and migration.
|
29146477 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
GFAP and S100 protein expressions in tumour cells from pituitary adenomas are influenced by hormone profile.
|
28660986 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Immunohistochemistry showed epithelioid cells with strong nuclear and cytoplasmic staining with S-100 protein, thus establishing the diagnosis of a melanocytic tumor.
|
22985334 |
2013 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The proportion of S-100+/CD1+ dermal DC deep to tumor is similar to that in normal epidermis and dermis, suggesting that there is no increased migration of S-100-/CD1+ DC from tumor-associated epidermis to subjacent dermis.
|
7680054 |
1993 |